These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19359464)

  • 1. Successful smoking cessation and improvement of negative symptoms with varenicline in a stable schizophrenia patient.
    Anghelescu I
    J Neuropsychiatry Clin Neurosci; 2009; 21(1):102-3. PubMed ID: 19359464
    [No Abstract]   [Full Text] [Related]  

  • 2. Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: a double-blind placebo and bupropion-controlled study.
    Fatemi SH; Yousefi MK; Kneeland RE; Liesch SB; Folsom TD; Thuras PD
    Schizophr Res; 2013 May; 146(1-3):376-8. PubMed ID: 23507358
    [No Abstract]   [Full Text] [Related]  

  • 3. Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia.
    Ismail Z; Syms J; Blumberger D; George TP
    Schizophr Res; 2010 Jun; 119(1-3):268. PubMed ID: 20178890
    [No Abstract]   [Full Text] [Related]  

  • 4. Varenicline modulates spatial working memory deficits in smokers with schizophrenia.
    Wing VC; Wass CE; Bacher I; Rabin RA; George TP
    Schizophr Res; 2013 Sep; 149(1-3):190-1. PubMed ID: 23849883
    [No Abstract]   [Full Text] [Related]  

  • 5. Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
    Smith RC; Lindenmayer JP; Davis JM; Cornwell J; Noth K; Gupta S; Sershen H; Lajtha A
    Schizophr Res; 2009 May; 110(1-3):149-55. PubMed ID: 19251401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varenicline efficacy and tolerability in a subject with schizophrenia.
    Fatemi SH
    Schizophr Res; 2008 Aug; 103(1-3):328-9. PubMed ID: 18572388
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
    J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial.
    Shim JC; Jung DU; Jung SS; Seo YS; Cho DM; Lee JH; Lee SW; Kong BG; Kang JW; Oh MK; Kim SD; McMahon RP; Kelly DL
    Neuropsychopharmacology; 2012 Feb; 37(3):660-8. PubMed ID: 22048460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity.
    Dutra SJ; Stoeckel LE; Carlini SV; Pizzagalli DA; Evins AE
    Psychopharmacology (Berl); 2012 Jan; 219(1):25-34. PubMed ID: 21695488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies.
    Cerimele JM; Durango A
    J Clin Psychiatry; 2012 Aug; 73(8):e1039-47. PubMed ID: 22967780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline, appetite, and weight reduction.
    Cocores JA; Gold MS
    J Neuropsychiatry Clin Neurosci; 2008; 20(4):497-8. PubMed ID: 19196942
    [No Abstract]   [Full Text] [Related]  

  • 12. Practical implementation of varenicline as an aid to smoking cessation in clinical practice.
    Tonstad S
    Pneumologia; 2009; 58(3):167-74. PubMed ID: 19817313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How well does the new drug varenicline work for people who want to stop smoking?
    Miller MC
    Harv Ment Health Lett; 2007 Jun; 23(12):8. PubMed ID: 17657893
    [No Abstract]   [Full Text] [Related]  

  • 14. [Varenicline (Champix)].
    Duh D; Macken E
    J Pharm Belg; 2007; 62(1):43-4. PubMed ID: 17508668
    [No Abstract]   [Full Text] [Related]  

  • 15. Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia.
    Liu ME; Tsai SJ; Jeang SY; Peng SL; Wu SL; Chen MC; Tsai YL; Yang ST
    Psychiatry Res; 2011 Nov; 190(1):79-84. PubMed ID: 21636135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
    Garza D; Murphy M; Tseng LJ; Riordan HJ; Chatterjee A
    Biol Psychiatry; 2011 Jun; 69(11):1075-82. PubMed ID: 21295286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline (CHANTIX): a stop-smoking pill.
    ORL Head Neck Nurs; 2006; 24(4):18-9. PubMed ID: 17390707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FDA approves new drug for smoking cessation.
    FDA Consum; 2006; 40(4):29. PubMed ID: 17243286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of varenicline for smoking cessation.
    Dervaux A; Kanit M; Laqueille X
    JAMA; 2006 Dec; 296(21):2555; author reply 2555-6. PubMed ID: 17148718
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of imbalance with varenicline Chantix(R): report of a patient with fragile X tremor/ataxia syndrome.
    Zesiewicz TA; Sullivan KL; Freeman A; Juncos JL
    Acta Neurol Scand; 2009 Feb; 119(2):135-8. PubMed ID: 18771524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.